Nilotinib Capsule
Product Images NDC 76282-789

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Nilotinib (NDC 76282-789). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 200mg Outer Carton (200mg Outer Carton)

Label 200mg Outer Carton (200mg Outer Carton)
Nilotinib Capsules 200 mg per capsule in a foldable carton packaging. The label shows the product name and strength prominently, along with dispensing instructions, storage warnings, and manufacturer information: Exelan Pharmaceuticals Inc. The package contains 112 capsules divided into four individual packs of 28 capsules each. The label design includes magenta and black text on a white background.*
FDA Label Image

Label Bottle 50 mg (50mg Bottle Label)

Label Bottle 50 mg (50mg Bottle Label)
Nilotinib 50 mg capsules label by Exelan Pharmaceuticals Inc. The label includes dosage strength, NDC number 76282-788-12, dispensing information, and storage instructions. It states the package contains 120 capsules and provides manufacturer details. Additional information includes batch number, expiration date, and barcode.*
FDA Label Image

Fig-1 (Fig 1)

Fig-1 (Fig 1)
A survival curve graph depicting treatment-free survival percentage over time in weeks for Nilotinib. The chart includes a main survival curve, dashed confidence intervals, and a table showing the number of patients at risk, events, and censored observations at various time points up to about 140 weeks.*
FDA Label Image

Fig-2 (Fig 2)

Fig-2 (Fig 2)
A Kaplan-Meier survival curve chart depicting treatment-free survival (%) over time in weeks since treatment-free remission (TFR). The chart includes median survival with censored observations marked and a table below showing patient numbers at risk, events, and censored counts at various time points up to 144 weeks.*
FDA Label Image

Label Outer Carton 150 mg (Outer Carton 150 mg)

Label Outer Carton 150 mg (Outer Carton 150 mg)
Nilotinib Capsules 150 mg per capsule carton label from Exelan Pharmaceuticals Inc. The label displays the product name, strength, and dosage form. It includes instructions for dispensing with a medication guide attached or provided separately. The carton contains 112 capsules in individual packs of 28 capsules each. The design features the Exelan Pharmaceuticals logo and a barcode.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of the active ingredient nilotinib, showing its molecular arrangement with aromatic rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.